Efficacy of the ERAS (enhanced recovery after surgery) program in elective total hip arthroplasty

Not Applicable

Recruiting

• Conditions: M16.0; M16.1; Primary coxarthrosis, bilateral; Other primary coxarthrosis

• Registration Number: DRKS00032262
• Lead Sponsor: Hospital of Traumatology and Orthopaedics

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-07-24
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 108

Inclusion Criteria

• Elective unilateral total hip arthroplasty due to osteoarthritis
• Age from 18 to 65 years
• Moves without assistive devices
• ASA 1-2
• BMI = 20-35.

Exclusion Criteria

• Refusal of the patient to participate in the study
• The patient does not understand the essence of the study
• Allergy to the medications included in the study
• Addiction to opioid analgesics before surgery
• Poorly compensated comorbidities
• Blood coagulation disorders
• After surgery, it is not possible to transfer the patient to the postoperative observation ward
• Local complication during surgery

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
number of days spent in hospital

Secondary Outcome Measures

Name	Time	Method
- HOOS, JR scale – number of points 6 weeks after surgery and change in number of points from the initial state the day before surgery.<br>- Satisfaction with treatment NRS from 0 to 10 on the day of discharge and 6 weeks after surgery.<br>- Pain NRS at rest and during movement on the day of discharge and 6 weeks after surgery.<br>- Morphine consumption on the day of surgery, on the first postoperative day, on the second postoperative day, and throughout the hospitalization period.